Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Nick Verougstraete

Showing results (1-10 of 27) with videos related to

Pageof 3
Sort By:
Journal of Pharmaceutical and Biomedical Analysis|October 16, 2021
Volumetric absorptive microsampling as a suitable tool to monitor tyrosine kinase inhibitorsNick Verougstraete, Christophe P Stove
Cell and Tissue Banking|December 16, 2019
Interpretation of EBV serology for human body material donors: Is there a need for early antigen IgG and heterophile antibodies testing?Nick Verougstraete, Elizaveta Padalko, Liselotte Coorevits
Clinical Chemistry and Laboratory Medicine|July 7, 2023
Remote HbA<sub>1c</sub> testing via microsampling: fit for purpose?Nick Verougstraete, Veronique Stove, Christophe P Stove
Therapeutic Drug Monitoring|September 18, 2025
Toward Clinical Implementation of a Volumetric Absorptive Microsampling-Based Method for Dasatinib and Imatinib Therapeutic Drug MonitoringNick Verougstraete, Dominiek Mazure, Christophe P Stove
Therapeutic Drug Monitoring|January 5, 2022
Automation in Busulfan Therapeutic Drug Monitoring: Evaluation of an Immunoassay on two Routine Chemistry AnalyzersNick Verougstraete, Veronique Stove, Alain G Verstraete, et al.
Talanta|March 7, 2021
Quantification of eight hematological tyrosine kinase inhibitors in both plasma and whole blood by a validated LC-MS/MS methodNick Verougstraete, Veronique Stove, Alain G Verstraete, et al.
Frontiers in Oncology|April 8, 2022
Therapeutic Drug Monitoring of Tyrosine Kinase Inhibitors Using Dried Blood MicrosamplesNick Verougstraete, Veronique Stove, Alain G Verstraete, et al.
Clinical Chemistry and Laboratory Medicine|November 30, 2019
Interference of anti-streptavidin antibodies in immunoassays: a very rare phenomenon or a more common finding?Nick Verougstraete, Mario Berth, Mario Vaneechoutte, et al.
Archives of Toxicology|September 25, 2025
Fast and reliable in vitro activity-based detection of synthetic cannabinoid receptor agonists in e-liquidsAxelle Timmerman, Cathelijne Lyphout, Nick Verougstraete, et al.
Drug Testing and Analysis|October 1, 2022
Identification of etazene (etodesnitazene) metabolites in human urine by LC-HRMSNick Verougstraete, Annick Verhaeghe, Jan Germonpré, et al.
Pageof 3

Showing results (1-10 of 27) with videos related to

Sort By:
Pageof 3
Journal of Pharmaceutical and Biomedical Analysis|October 16, 2021
Volumetric absorptive microsampling as a suitable tool to monitor tyrosine kinase inhibitorsNick Verougstraete, Christophe P Stove
Cell and Tissue Banking|December 16, 2019
Interpretation of EBV serology for human body material donors: Is there a need for early antigen IgG and heterophile antibodies testing?Nick Verougstraete, Elizaveta Padalko, Liselotte Coorevits
Clinical Chemistry and Laboratory Medicine|July 7, 2023
Remote HbA<sub>1c</sub> testing via microsampling: fit for purpose?Nick Verougstraete, Veronique Stove, Christophe P Stove
Therapeutic Drug Monitoring|September 18, 2025
Toward Clinical Implementation of a Volumetric Absorptive Microsampling-Based Method for Dasatinib and Imatinib Therapeutic Drug MonitoringNick Verougstraete, Dominiek Mazure, Christophe P Stove
Therapeutic Drug Monitoring|January 5, 2022
Automation in Busulfan Therapeutic Drug Monitoring: Evaluation of an Immunoassay on two Routine Chemistry AnalyzersNick Verougstraete, Veronique Stove, Alain G Verstraete, et al.
Talanta|March 7, 2021
Quantification of eight hematological tyrosine kinase inhibitors in both plasma and whole blood by a validated LC-MS/MS methodNick Verougstraete, Veronique Stove, Alain G Verstraete, et al.
Frontiers in Oncology|April 8, 2022
Therapeutic Drug Monitoring of Tyrosine Kinase Inhibitors Using Dried Blood MicrosamplesNick Verougstraete, Veronique Stove, Alain G Verstraete, et al.
Clinical Chemistry and Laboratory Medicine|November 30, 2019
Interference of anti-streptavidin antibodies in immunoassays: a very rare phenomenon or a more common finding?Nick Verougstraete, Mario Berth, Mario Vaneechoutte, et al.
Archives of Toxicology|September 25, 2025
Fast and reliable in vitro activity-based detection of synthetic cannabinoid receptor agonists in e-liquidsAxelle Timmerman, Cathelijne Lyphout, Nick Verougstraete, et al.
Drug Testing and Analysis|October 1, 2022
Identification of etazene (etodesnitazene) metabolites in human urine by LC-HRMSNick Verougstraete, Annick Verhaeghe, Jan Germonpré, et al.
Pageof 3